* Drug will compete with AstraZeneca’s Symbicort (Updates with FDA comment, side effects)
* Panel votes Breo effective in treating airflow obstruction
(Reuters) – An advisory panel to the U.S. Food and Drug Administration has recommended that the agency approve an experimental treatment for smoking-related lung damage made by Britain’s GlaxoSmithKline Plc and Theravance Inc.
(Reuters) – Oncolytics Biotech Inc said its experimental lung cancer drug was found to be more effective in a mid-stage trial study, sending its shares up more than 10 percent.
NEW YORK (Reuters Health) – Black lung cancer patients seem more likely to die of the disease than white cancer patients in the U.S., especially those living in segregated counties, according to a new study.
(Reuters) – A small early-stage trial of Ariad Pharmaceuticals Inc’s experimental pill AP26113 showed it shrank tumors in eight out of 11 lung cancer patients with a genetic mutation in a gene known as ALK.
What is Mesothelioma Lung Cancer? Article by Johanes Stones Mesothelioma is nothing but a cancer of … Continue reading
Asbestos Lung Cancer Article by KemanS Asbestos Lung Cancer or scientifically known as bronchial carcinoma or … Continue reading
NEW YORK, Sept 7 (Reuters) – Peregrine Pharmaceuticals Inc : * Pharma surges 56.4 percent to $ 4.80 after non-small cell lung cancer trial results